Wolverine Asset Management LLC Incyte Corp Put Options Transaction History

Wolverine Asset Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $756,364 - $1.05 Million	-11,900 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $596,700 - $713,388	-10,200 Reduced 46.15%	11,900 $756,000
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $1.3 Million - $1.56 Million	-21,000 Reduced 48.72%	22,100 $1.53 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $1.87 Million - $2.58 Million	30,700 Added 247.58%	43,100 $2.89 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $830,600 - $1.01 Million	-10,000 Reduced 44.64%	12,400 $1.03 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $1.16 Million - $1.45 Million	12,400 Added 124.0%	22,400 $2.12 Million
Q2 2017 Aug 14, 2017	BUY	N/A	10,000	10,000 $1.26 Million

641

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.